Wenwei Hu

15.1k citations

142 papers · 11.7k indexed · 4 hit papers · h-index 57

Impact in

Cancer Research top 0.2%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
Oncology top 0.5%
- Cancer-related Molecular Pathways

Papers in

Oncology 88
- Cancer-related Molecular Pathways 58
- Cytokine Signaling Pathways and Interactions 11
Cancer Research 44
- Cancer, Hypoxia, and Metabolism 27

Co-authors: Zhaohui Feng Arnold J. Levine Cen Zhang Yuhan Zhao Rui Wu Gareth L. Bond Angelika K. Teresky Juan Liu
Journals: Proceedings of the National Academy of Sciences (9 papers)Nature Communications (8 papers)Oncotarget (7 papers)Biochemistry (4 papers)Cancer Research (4 papers)
Partner nations: United States China Singapore

In The Last Decade

Wenwei Hu

139 papers receiving 11.5k citations

Hit Papers

align trajectories log scale

Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function 2010 · 673 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2010 Proceedings of the National Academy of Sciences
2007 Cancer Research
2006 Cell Death and Differentiation
2004 Cell

Peers

Countries citing papers authored by Wenwei Hu

Since Specialization

Citations

This map shows the geographic impact of Wenwei Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenwei Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenwei Hu more than expected).

Fields of papers citing papers by Wenwei Hu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenwei Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenwei Hu. The network helps show where Wenwei Hu may publish in the future.

Co-authors

The 25 scholars most cited alongside Wenwei Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Wenwei Hu Line = papers co-authored together Wenwei Hu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Lactylation-driven MVP upregulation boosts immunotherapy resistance by inhibiting PD-L1 degradation in hepatocellular carcinoma Journal for ImmunoTherapy of Cancer ·Shuang Liu, I. E. Aronov, Res. Assist. Dr. Ayşe Kizildağ, Melissa Otero, Ruonan Shao, Qi Wang, Jun Wu, Chen Wu, Wenwei Hu, Jun Xu, Changping Wu, Jingting Jiang	2025	1
2	p53 suppresses MHC class II presentation by intestinal epithelium to protect against radiation-induced gastrointestinal syndrome Nature Communications ·Jianming Wang, Erin Quinlan, Xue Yang, Shinya Tawaratsumida, Sarah Noami Lewis, Jill Bargonetti, Lanjing Zhang, Ping Xie, Zhaohui Feng, Wenwei Hu	2024	13
3	EP07.05-14 HRQoL with Adjuvant Aumolertinib in Patients with Resected Stage IB-IIIA EGFR Mutant Non Small Cell Lung Cancer Journal of Thoracic Oncology ·Wenwei Hu, Ferdi Nanda Hafni, Ninghui Cheng, D. Vongsasitorn, Zhiyuan Tang	2023	1
4	Inhibition of autophagy and MEK promotes ferroptosis in Lkb1-deficient Kras-driven lung tumors Cell Death and Disease ·Vrushank Bhatt, Taijin Lan, Wenping Wang, 永昌岡島, 水野澄子, Jianming Wang, Khoosheh Khayati, 张虎安, Mona Boord, 鲁秀萍, Zhixian Hu, Savita Kumari, Xiaoyang Su, Jyoti Malhotra, Wenwei Hu, Sharon R. Pine, Eileen White, Jessie Yanxiang Guo	2023	33
5	The ubiquitin ligase TRIM21 regulates mutant p53 accumulation and gain of function in cancer Journal of Clinical Investigation ·Juan Liu, Cen Zhang, Dandan Xu, Tianliang Zhang, Erin Quinlan, Jianming Wang, Jie Liu, Lanjing Zhang, Bruce G. Haffty, Wei‐Xing Zong, Wenwei Hu, Zhaohui Feng	2023	41
6	Metabolic enzyme LDHA activates Rac1 GTPase as a noncanonical mechanism to promote cancer Nature Metabolism ·Juan Liu, Cen Zhang, Tianliang Zhang, Erin Quinlan, Jianming Wang, Mamiko Odani, Lanjing Zhang, Bruce G. Haffty, Wenwei Hu, Zhaohui Feng	2022	56
7	Tumor suppressor p53 regulates intestinal type 2 immunity Nature Communications ·Erin Quinlan, Jianming Wang, Yuhan Zhao, Juan Liu, Xue Yang, Xuetian Yue, Huaying Wang, Shinya Tawaratsumida, Juan M. Inclan-Rico, А. Г. Фомин, Ping Xie, Lanjing Zhang, Mark C. Siracusa, Zhaohui Feng, Wenwei Hu	2021	26
8	Autophagy promotes mammalian survival by suppressing oxidative stress and p53 Genes & Development ·Yang Yang, Gizem Karsli-Uzunbas, Laura Poillet-Perez, クリトファー・P フッド, Zhixian Hu, Yuhan Zhao, Dirk F. Moore, Wenwei Hu, Eileen White	2020	78
9	Elevating EGFR-MAPK program by a nonconventional Cdc42 enhances intestinal epithelial survival and regeneration JCI Insight ·Xiao Zhang, Sheila Bandyopadhyay, Leandro P. Araújo, Kevin Tong, Juan Flores, Daniel Laubitz, Yanlin Zhao, George Yap, Елена Владимировна Яушева, Qingze Zou, Ronaldo P. Ferraris, Lanjing Zhang, Wenwei Hu, Edward M. Bonder, Pawel R. Kiela, Robert J. Coffey, Michael P. Verzi, Ivaylo I. Ivanov, Nan Gao	2020	23
10	Association of KRAS mutation with tumor deposit status and overall survival of colorectal cancer Cancer Causes & Control ·Meifang Zhang, Wenwei Hu, Kun Hu, Yong Lin, Zhaohui Feng, Jing‐Ping Yun, Nan Gao, Lanjing Zhang	2020	11
11	Lycorine Promotes Autophagy and Apoptosis via TCRP1/Akt/mTOR Axis Inactivation in Human Hepatocellular Carcinoma Molecular Cancer Therapeutics ·Haiyang Yu, Yuling Qiu, Xu Pang, Jian Li, Song Wu, Shuangshuang Yin, Lifeng Han, Yi Zhang, Cheng‐Yun Jin, Xiumei Gao, Wenwei Hu, Tao Wang	2017	72
12	Mutant p53 in Cancer: Accumulation, Gain-of-Function, and Therapy Journal of Molecular Biology ·Xuetian Yue, Yuhan Zhao, Yang Xu, Min Zheng, Zhaohui Feng, Wenwei Hu	2017	236
13	HIF-2α mediates hypoxia-induced LIF expression in human colorectal cancer cells Oncotarget ·Lihua Wu, Haiyang Yu, Yuhan Zhao, Cen Zhang, Jiabei Wang, Xuetian Yue, Qifeng Yang, Wenwei Hu	2015	41
14	Gene Amplifications in Well-Differentiated Pancreatic Neuroendocrine Tumors Inactivate the p53 Pathway Genes & Cancer ·Wenwei Hu, Zhaohui Feng, Fabiola Silveira Maranhão, David S. Klimstra, Ling Song, Peter J. Allen, Murray F. Brennan, Arnold J. Levine, Laura H. Tang	2010	82
15	Single-nucleotide polymorphisms in the p53 pathway regulate fertility in humans Proceedings of the National Academy of Sciences ·Hey‐Joo Kang, Zhaohui Feng, Yvonne Sun, Gurinder S. Atwal, Maureen E. Murphy, Timothy R. Rebbeck, Zev Rosenwaks, Arnold J. Levine, Wenwei Hu	2009	157
16	The tumor suppressor p53: Cancer and aging Cell Cycle ·Zhaohui Feng, Wenwei Hu, G. Rajagopal, Arnold J. Levine	2008	86
17	The Regulation of AMPK β1, TSC2, and PTEN Expression by p53: Stress, Cell and Tissue Specificity, and the Role of These Gene Products in Modulating the IGF-1-AKT-mTOR Pathways Cancer Research ·Zhaohui Feng, Wenwei Hu, Elisa de Stanchina, Angelika K. Teresky, Shengkan Jin, Scott W. Lowe, Arnold J. Levine Hit paper breakdown →	2007	505
18	Declining p53 function in the aging process: A possible mechanism for the increased tumor incidence in older populations Proceedings of the National Academy of Sciences ·Zhaohui Feng, Wenwei Hu, Angelika K. Teresky, Eva Hernando, Carlos Cordon‐Cardo, Arnold J. Levine	2007	208
19	Acrolein is a major cigarette-related lung cancer agent: Preferential binding at p53 mutational hotspots and inhibition of DNA repair Proceedings of the National Academy of Sciences ·Zhaohui Feng, Wenwei Hu, Yu Hu, Moon‐shong Tang	2006	307
20	Transcription-coupled and Transcription-independent Repair of Cyclobutane Pyrimidine Dimers in the Dihydrofolate Reductase Gene Journal of Biological Chemistry ·Wenwei Hu, Zhaohui Feng, Lawrence A. Chasin, Moon‐shong Tang	2002	19

About Wenwei Hu

Wenwei Hu is a scholar working on Oncology, Cancer Research, Molecular Biology, Immunology and Biochemistry, having authored 142 papers that have together received 11.7k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (58 papers), Cancer, Hypoxia, and Metabolism (27 papers), DNA Repair Mechanisms (21 papers), Epigenetics and DNA Methylation (20 papers), Ubiquitin and proteasome pathways (13 papers), Cytokine Signaling Pathways and Interactions (11 papers), Reproductive System and Pregnancy (11 papers) and RNA modifications and cancer (9 papers). The work is most often cited by research in Cancer Research (3.8k citations), Oncology (4.7k citations), Molecular Biology (7.5k citations), Aging (124 citations) and Biotechnology (605 citations). Wenwei Hu has collaborated with scholars based in United States, China and Singapore. Frequent co-authors include Zhaohui Feng, Arnold J. Levine, Cen Zhang, Yuhan Zhao, Rui Wu, Gareth L. Bond, Angelika K. Teresky, Juan Liu, Yvonne Sun and Xuetian Yue. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications, Oncotarget, Biochemistry and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact